Lovely Meds Review: What the First Payment and Monthly Prices Really Tell You

A $39 first month is an attention-grabbing price, but it is not enough information to build a treatment budget. Lovely Meds advertises that introductory figure for compounded semaglutide alongside a starting rate of $99 per month. Its pricing table connects the $99 rate to a 12-month option, while the one-month option costs $175. The central cost question is therefore not simply whether the promotion exists, but what order, payment and shipment arrangements accompany it.

Lovely Meds presents a U.S. telehealth platform offering access to compounded injectable and oral treatments alongside branded products. This documentary review examines the supplied pages and terms, consulted October 19, 2026, rather than a completed purchase. The website provides useful prices and assigns responsibilities among the platform, clinicians and pharmacies. However, it does not fully explain the initial checkout amount for longer options, subsequent purchasing arrangements or how several overlapping cancellation provisions work together.

At a glance

Compounded semaglutide pricing: The injection-kit table lists $175/month for one month, $145/month for three months, $120/month for six months and $99/month for 12 months.
Sources: [8]
Compounded tirzepatide pricing: The injectable offering lists $235/month for one month, $199/month for three months, $175/month for six months and $150/month for 12 months.
Sources: [12]
Purchase structure: The terms describe all orders as one-time purchases, despite the website's monthly price displays; longer-option payment and shipment schedules remain unclear.
Sources: [15]
Clinical review: Prescriber review is automatically included in the order and is not separately billed. A prescription is not guaranteed.
Sources: [15]
Insurance and benefits: Lovely Meds does not bill insurance directly. Possible out-of-network reimbursement or HSA/FSA use must be checked with the insurer or benefits administrator.
Sources: [7]

Start with the order total, not the promotional headline

The compounded semaglutide injection-kit page advertises a starting price of $99 per month and a $39 first month for new customers through NEW60, described as applied automatically at checkout. Its table assigns the $99 monthly rate to a 12-month option. The corresponding compounded tirzepatide page advertises $150 per month and a $90 first month under the same promotion, again with the lowest table rate attached to 12 months. Neither headline establishes a standalone, no-commitment monthly offer.

Both tables say all doses have the same price, with plans based on frequency. The semaglutide page nevertheless also says pricing varies by prescribed strength and formulation. That is a meaningful inconsistency when estimating costs, not a reason to disregard the published figures. Ask for the price of the actual prescribed formulation and selected duration, including the amount collected immediately. The site's longer-duration labels do not, by themselves, establish full upfront payment, supply quantity or a minimum contractual commitment.

The practical distinction is between a monthly price expression and an actual charge. Before submitting payment, obtain the order total, how the introductory discount is allocated and whether any balance will be collected later. Our explanation of why the first payment can differ from the advertised monthly price provides a useful framework. Lovely Meds' supplied material does not settle those questions for its three-, six- and 12-month options.

Published monthly rates for the compounded injectable offerings; collection and shipment schedules are not established by this table.
Listed duration	Semaglutide injection kit with B12	Compounded tirzepatide with B12
1 month	$175/month	$235/month
3 months	$145/month	$199/month
6 months	$120/month	$175/month
12 months	$99/month	$150/month

Sources: [8] [12]

Oral products have different prices and different presentations

The oral listings should not be treated as interchangeable versions of the injectable price menu. Compounded semaglutide ODT is advertised from $209 per month, with a $149 first month for new customers using NEW60. Compounded tirzepatide ODT starts at $259 per month, with a $199 first month under that promotion. Both are described as pharmacy-prepared products that dissolve under the tongue without injections. Their supplied headline offers do not specify a minimum duration or complete order total.

Semaglutide drops use a different promotion: from $199 per month, with NEW15 advertised as a 15% new-customer discount and the first month shown as $169. The broader catalog also lists oral tirzepatide drops and a sublingual semaglutide troche, but detailed documentation was not supplied for every listing. The advertised price for one oral presentation therefore should not be carried over to another. Nor does a shared ingredient name establish equivalent clinical evidence across routes.

The branded listings introduce another price category. Lovely Meds advertises Wegovy tablets from $299 per month, plus $60 off the first order with NEW60, and describes a one-month bottle containing 30 tablets. Foundayo, identified by the site as oral orforglipron, also starts at $299 per month for a one-month supply with $60 off the first order. These remain starting prices. Product-approval statements are the site's claims; a copied Foundayo block within the Wegovy page further limits confidence in that page's product-specific detail.

Sources: [5] [13] [10] [6] [9] [4]

One-time purchases do not explain the next payment

Lovely Meds' terms explicitly describe all orders as one-time purchases. That matters: the presence of a monthly rate is not sufficient evidence of an automatically renewing subscription. However, the supplied pages do not explain subsequent repurchases, whether a new clinical review occurs with each order or how a longer-duration option is divided into shipments. A buyer should not assume either automatic continuation or automatic monthly delivery from the pricing language alone.

The terms also allow prices, product availability and shipping timelines to change without notice. The supplied documentation does not establish that an introductory offer protects future repurchase prices. Nor does the phrase “first month” explain exactly how a discount applies across each available duration. The useful comparison is the written transaction being offered now, followed by the documented process for obtaining more medication—not an annual total extrapolated from the smallest advertised monthly number.

One cost is expressly included: the terms say prescriber review is automatically part of the order and is not separately billed. Beyond that, the supplied evidence does not itemize every possible shipping, tax, supply or laboratory charge, or establish whether particular cases incur additional fees. Readers can use our guide to what a GLP-1 program price includes to separate confirmed inclusions from questions that still need a written answer.

Sources: [15]

Cancellation can cost money before medication ships

The cancellation terms deserve attention before checkout, not after a change of plans. They impose a $40 administrative fee when an order is canceled before provider review begins. Another provision describes a $40 fee after prescriber review but before pharmacy dispatch. Yet the same terms say an order becomes final and cannot be canceled once the prescription is finalized and sent to the pharmacy. Those milestones can occur before a package leaves the pharmacy, making the practical cutoff unclear.

After the pharmacy has labeled and shipped medication, the terms prohibit cancellations, returns and refunds. Shipping damage or a defect may result in a replacement only; the language does not promise an automatic replacement or cash refund. Separate multipack provisions allow requests for refunds on unopened, unused packs before shipment. Packs already shipped or used are recalculated at the standard single-pack price, and a 10% administrative fee is deducted from the refundable balance.

These multipack rules mean that an unused portion need not retain its original discounted valuation. The supplied terms do not fully reconcile that provision with the earlier final-sale language. Ask which rule applies to the selected order and what event ends cancellation rights. Refunds are to be issued within 15 U.S. business days; that is not a guarantee of bank receipt within that period. Our cancellation and refund guide explains why stopping an order and recovering money are separate questions.

Sources: [15]

Know who provides the care behind the price

Lovely Meds, Inc. identifies itself as a technology platform, not a medical provider. Its terms assign independent clinical evaluations and prescribing decisions to licensed healthcare providers affiliated with Beluga Health, P.A. and affiliated medical groups. The intake asks about medical history, medications, allergies and goals; a clinician may ask follow-up questions before deciding. The terms do not guarantee a prescription and state that controlled substances are not prescribed. The advertised purchase process therefore remains subject to clinical review.

The site requires users to be at least 18. Availability is limited to U.S. states where the Beluga Health Provider Group is authorized to operate, and the terms prohibit access from outside the United States. The semaglutide page specifically excludes Kansas, Louisiana, Mississippi and New Mexico, but that is not a complete product-by-product service map. Its stated consideration criteria are BMI 27 or higher, or 25 or higher with a weight-related condition, subject to specialist judgment—not independently established eligibility for a reader. The site's FAQ also states that these treatments should not be used by people with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN-2), and advises discussing risks with a licensed healthcare professional.

A microdosing page describes a form-based process with no required phone or video visits; that description should not be generalized to every offering. The FAQ separates order and platform support from medical questions, directing the latter to a healthcare professional involved in treatment. No routine follow-up cadence, required laboratory schedule, medical response time or after-hours clinical access is documented in the supplied material. Consequently, the published price alone does not describe the full ongoing care arrangement.

Sources: [15] [7] [11] [8]

Pharmacy and delivery arrangements affect the purchase

Lovely Meds says it does not compound medication itself. Independent U.S. compounding pharmacies prepare and ship prescriptions after a valid prescription is issued. The general notice allows patients to request an alternative to partner pharmacies, but does not explain resulting pricing or fulfillment changes. No specific dispensing pharmacy names or independently verified license details appear in the supplied evidence. The compounded tirzepatide with B12 offering describes subcutaneous medication generally supplied in sterile vials with syringes and pharmacy labeling.

The semaglutide injection kit is also advertised with B12, with the page describing subcutaneous administration from sterile vials. Packaging may differ from website images. A process page advertises delivery to the home within three to five business days, but does not identify when that clock begins. The FAQ says pharmacy preparation and shipping follow prescription issuance, with tracking typically supplied after dispatch. That does not establish separate clinical-review, preparation and transit deadlines.

Orders are described as arriving in standard packaging without visible medication names. For delays or missing deliveries, support offers to coordinate an investigation with the pharmacy or carrier, rather than promising an automatic refund. The supplied pages do not explain injectable cold-chain procedures. FDA advises not using an injectable GLP-1 drug that arrives warm or inadequately refrigerated and contacting the provider or dispensing pharmacy. A delivery problem therefore needs both a fulfillment response and, when relevant, a clinical or pharmacy response.

Sources: [7] [6] [12] [8] [14] [1]

Self-pay, support and privacy need separate answers

Lovely Meds does not bill insurance directly. Its FAQ suggests checking possible out-of-network reimbursement or HSA/FSA use with the insurer or benefits provider. The semaglutide injection kit is marked FSA/HSA eligible, but that website label should not replace confirmation from the relevant administrator. These are different questions from whether a particular medication is covered. Our guide to insurance and self-pay questions can help organize the information needed before treating a potential benefit as part of the budget.

For contact, the site publishes +1 313 334 7322. It lists weekday contact hours of 8 a.m. to 2 p.m. EST and separate opening hours of 8 a.m. to 5 p.m. EST, with weekends closed. Those differing windows do not establish continuous support or clinical availability. Before purchasing, identify the correct route for an order correction, a billing dispute and a medical concern, especially because the FAQ assigns medical questions to the professional involved in care.

Privacy descriptions also have different scopes. The FAQ describes information sharing in connection with care, while the footer discloses limited use of de-identified data for Google and Facebook advertising, including reaching new patients or excluding existing ones. Discreet delivery packaging does not resolve that separate data-use question. The full independent privacy-practices documentation was not supplied, so the evidence supports flagging the distinction, not making a broader conclusion about privacy compliance or confidentiality.

Sources: [8] [7] [6]

A lower price does not settle the evidence question

Lovely Meds discloses that compounded semaglutide and tirzepatide are not FDA approved and have not undergone FDA review for safety, efficacy or quality. FDA recommends compounded drugs when an individual's medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not prove clinical inequivalence. It also does not permit transferring results from approved products to this platform's compounded preparations, oral routes, microdoses or vitamin blends.

Several documentation problems make precise product confirmation especially useful. The FAQ says the business is not marketing compounds based on a current shortage, while the footer still references FDA-declared shortages. Some semaglutide material contains tirzepatide-related control or dispensing text. Website descriptions of checks are not batch certificates or independent verification. Similarly, a statement about approval of a particular branded product would not establish approval of Lovely Meds, an affiliated pharmacy or a compounded formulation.

Sources: [6] [7] [8] [5] [1] [2] [3]

Questions & answers

Can I assume Lovely Meds semaglutide costs $39 for a standalone month?

No. The page advertises a $39 first month for new customers using NEW60 alongside a $99 starting monthly rate. Its table connects $99 to the 12-month option and lists $175 for the one-month option. The supplied material does not explain the complete checkout amount or how the introductory promotion applies to each duration. Request those details before paying.

Sources: [8]

Does Lovely Meds automatically renew orders every month?

The terms say all orders are processed as one-time purchases, so an automatic monthly subscription is not established. However, the supplied pages do not fully explain repurchasing, later charges or shipment schedules for longer options. Ask whether any future payment authorization exists and how another prescription order is requested rather than assuming the monthly price describes the billing mechanism.

Sources: [15]

Is the clinician review a separate charge?

According to the terms, prescriber review is automatically included in the order and is not separately billed. That does not establish that every possible service is included: the supplied evidence does not fully itemize laboratory, shipping, supply or case-specific charges. It also does not explain a guaranteed prescription or a standardized package of ongoing clinical follow-up.

Sources: [15] [7]

Can I cancel before the pharmacy ships?

Do not assume that shipment is the only cutoff. The terms describe $40 cancellation fees before review and after review before dispatch, but also say the order becomes final once the prescription is finalized and sent to the pharmacy. Multipacks have additional refund provisions. Obtain confirmation of the applicable cutoff and refundable amount for your specific order.

Sources: [15]

Who actually prepares and sends the medication?

Lovely Meds says independent, state-licensed U.S. compounding pharmacies prepare and ship compounded prescriptions; the platform does not compound them itself. Its notice permits requesting an alternative pharmacy. The supplied evidence does not identify the specific dispensing pharmacies or explain the cost consequences of using an alternative, so request the pharmacy name and fulfillment terms before relying on the advertised arrangement.

Sources: [7] [6]

Does Lovely Meds accept insurance or guarantee HSA/FSA reimbursement?

Lovely Meds says it does not bill insurance directly. It advises checking out-of-network reimbursement and HSA/FSA possibilities with the insurer or benefits provider. Although its semaglutide injection kit carries an FSA/HSA eligibility label, the supplied documentation does not guarantee reimbursement or individual account eligibility. Confirm the expense, required documentation and applicable benefits rules directly with the administrator.

Sources: [7] [8]

Our assessment

Lovely Meds provides more concrete pricing than a single starting-price advertisement: its injectable duration tables, oral-product offers and included prescriber review give buyers useful comparison points. Its one-time-purchase terms also distinguish it from a clearly documented recurring subscription. The weakness is the connection between those figures and the transaction itself. Longer-option collection schedules, future purchases, all-in fees and overlapping cancellation cutoffs remain insufficiently explained. Product-page inconsistencies add another reason to request a formulation-specific written quote. Before paying, obtain the immediate charge, any later payment obligations, shipment schedule, dispensing pharmacy, cancellation milestone and route for clinical follow-up. Those answers—not the lowest first-month headline—determine whether the documented offer fits a workable budget.

Visit Lovely Meds’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

Lovely Meds Review: What the First Payment and Monthly Prices Really Tell You

At a glance

01Start with the order total, not the promotional headline

02Oral products have different prices and different presentations

03One-time purchases do not explain the next payment

04Cancellation can cost money before medication ships

05Know who provides the care behind the price

06Pharmacy and delivery arrangements affect the purchase

07Self-pay, support and privacy need separate answers

08A lower price does not settle the evidence question

Questions & answers

Our assessment

Sources & documentation

Continue reading

Start with the order total, not the promotional headline

Oral products have different prices and different presentations

One-time purchases do not explain the next payment

Cancellation can cost money before medication ships

Know who provides the care behind the price

Pharmacy and delivery arrangements affect the purchase

Self-pay, support and privacy need separate answers

A lower price does not settle the evidence question